Annual Report

Overview

The report presents Grand Pharmaceutical Group's 2022 growth in pharmaceutical technology, nuclear medicine and cerebro-cardiovascular precision intervention, including commercialization of Yttrium-90 microsphere injections in China. Its ESG section reports 10,172 employees, direct GHG emissions of 68,362 Tons of CO 2 equivalent per annum and indirect emissions of 133,677 Tons of CO 2 equivalent per annum. The Group also reports no work-related fatalities and continued EHS and anti-corruption controls. The Board is assigned overall responsibility for ESG strategy and reporting.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2022
Period: 1 January 2022 – 31 December 2022
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services